Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.90
Bid: 31.80
Ask: 32.00
Change: 0.50 (1.59%)
Spread: 0.20 (0.629%)
Open: 31.40
High: 32.20
Low: 31.35
Prev. Close: 31.40
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Rights Issue and placing of rump

22 Jul 2009 12:30

RNS Number : 0983W
Marston's PLC
22 July 2009
 



THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

22 July 2009

Marston's PLC ("Marston's" or "the Company")

Successful completion of Rights Issue and placing of rump

Marston's announced previously that it had received valid acceptances in respect of 273,269,134 New Shares, representing approximately 91.44% per cent of the total number of New Shares offered to Qualifying Shareholders, pursuant to the Rights Issue announced by the Company on 18 June 2009. 

Marston's confirms that, in accordance with the arrangements set out in Parts III and VII of the prospectus sent to Shareholders dated 18 June 2009 ("Prospectus"), RBS Hoare Govett and J.P. Morgan Cazenove, acting as Joint Bookrunners, have today procured subscribers for the 25,596,096 remaining New Shares not validly taken up, at a price of 85 pence per New Share. The net proceeds from the sale of such New Shares, after deduction of the Issue Price of 59.0 pence per New Share and the expenses of procuring subscribers (including any applicable brokerage and commissions and amounts in respect of VAT), will be paid to those Shareholders whose rights have lapsed in accordance with the terms of the Rights Issue, pro rata to the relevant provisional allotments not taken up, save that amounts of less than £5.00 per holding will not be so paid but will be aggregated and will accrue for the benefit of the Company. 

Unless otherwise defined in this announcement, capitalised terms shall have the meaning given to them in the Prospectus.

Contacts

For further information please contact:

Marston's PLC

+44 (0)1902 711 811

Ralph Findlay, Chief Executive

Andrew Andrea, Finance Director

Hudson Sandler:

+44(0)20 7796 4133

Andrew Hayes

Nick Lyon

James White

DISCLAIMER

This announcement does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security.

This announcement is an advertisement and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement should be interpreted as a term or condition of the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Provisional Allotment Letter, Nil Paid Rights, Fully Paid Rights, and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus. Copies of the Prospectus are available at the Company's registered office.

RBS Hoare Govett, J.P. Morgan Cazenove and Rothschild, which are regulated in the United Kingdom by the Financial Services Authority, are acting exclusively for the Company and for no-one else in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to their respective customers or for providing advice in relation to the Rights Issue or the contents of this announcement or any of the other matters referred to in this announcement.

The New Shares, the Nil Paid Rights, the Fully Paid Rights and the Provisional Allotment Letters have not been and will not be registered under the US Securities Act of 1933, as amended (the US Securities Act) and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, in the United States absent registration or pursuant to an exemption from, or in transactions not subject to, the registration requirements of the US Securities Act.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFXAAAXNEFE
Date   Source Headline
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company
18th Feb 20221:09 pmRNSHolding(s) in Company
25th Jan 20222:35 pmRNSTrading for the period to 22 Jan 2022 - Correction
25th Jan 20222:20 pmRNSResult of AGM
25th Jan 20227:00 amRNSTrading for the 16-week period to 22 January 2022
10th Jan 20223:55 pmRNSBlock listing Interim Review
20th Dec 20214:15 pmRNSAnnual Financial Report
7th Dec 202111:11 amRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSRESULTS FOR THE 52 WEEKS ENDED 2 OCTOBER 2021
19th Oct 20219:05 amRNSHolding(s) in Company
13th Oct 20217:00 amRNSYear end trading update
30th Sep 202110:43 amRNSDisclosure of 2020/21 LTIP performance targets
16th Sep 20213:00 pmRNSDirector Declaration re: New Directorship
9th Sep 20212:30 pmRNSDirector/PDMR Shareholding
28th Jul 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.